-
Membrane ‘neighborhood’ helps transporter protein regulate cell signaling
12/05/2025
See how protein kinase A, SCRIB, and other proteins help keep ABCC4 transporter levels steady in the membrane to regulate cyclic AMP signaling
-
Research reveals how disordered protein regions contribute to cancer-causing condensates
12/03/2025
See how scientists use IDR-Puncta ML to predict which fusion oncoproteins form condensates, revealing new insights into cancer and RNA biology.
-
Spatial Touchstone brings quality control to spatial transcriptomics
12/03/2025
Explore Spatial Touchstone’s open-source tools and data for standardized spatial transcriptomics, enabling reliable, cross-institutional gene expression analysis.
-
Research reveals structural mechanism behind anti-epilepsy therapies
12/01/2025
Learn how epilepsy drugs reshape SV2A and how new modulators boost potency, paving the way for more effective epilepsy treatments.
-
Inflammation and metabolic stress combine to drive a new cell death pathway: mitoxyperilysis
11/28/2025
Discover how St. Jude research uncovered an unknown cell death pathway triggered by innate immune activation and nutrient scarcity that may help treat cancer.
-
St. Jude method democratizes access to T-cell receptor analysis
11/24/2025
Speed up analysis of T cells with the scalable and cost-effective TIRTL-sequencing method invented by St. Jude scientists, as published in Nature Methods.
-
2025 Highly Cited Researchers list highlights St. Jude scientific impact
11/13/2025
St. Jude researchers among nationally recognized highly cited researchers
-
AlphaSync database keeps protein structure prediction resource up to date
11/11/2025
Discover how St. Jude scientists created AlphaSync, a database that keeps protein predictions up to date to push science forward & prevents cascading errors.
-
Gene therapy for sickle cell and β-thalassemia works by disrupting three-dimensional genome structure
11/10/2025
See how scientists identified a previously unknown treatment opportunity for sickle cell disease and β-thalassemia based on how CRISPR-based gene therapy works
-
Largest study on infant-type hemispheric glioma reports factors to guide treatment approaches
11/10/2025
Largest global study of infant hemispheric glioma identifies prognostic factors to guide safer, more effective treatments.
Explore more research news
More Research News
-
Scientific Report
St. Jude Researchers, backed by extraordinary resources and support teams, are focused on making big discoveries.
Clinical Trials Alerts
Our e-newsletter for clinicians offers updates on St. Jude open clinical trials and research news.
Follow Us on Social Media
Connect with @stjuderesearch to keep up with our latest science and medical news. More about St. Jude social media.
Peer-Reviewed Publications
Browse all scientific publications by St. Jude investigators.